Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022

SELL
$141.59 - $168.66 $1,699 - $2,023
-12 Reduced 0.44%
2,688 $419,000
Q1 2022

Apr 22, 2022

BUY
$129.64 - $160.7 $294,282 - $364,789
2,270 Added 527.91%
2,700 $420,000
Q3 2021

Oct 12, 2021

SELL
$128.64 - $184.79 $128,639 - $184,790
-1,000 Reduced 69.93%
430 $56,000
Q2 2021

Jul 20, 2021

BUY
$160.2 - $186.42 $229,085 - $266,580
1,430 New
1,430 $254,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Equitec Proprietary Markets, LLC Portfolio

Follow Equitec Proprietary Markets, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitec Proprietary Markets, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Equitec Proprietary Markets, LLC with notifications on news.